ATYR Long Put Strategy
ATYR (aTyr Pharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis.
ATYR (aTyr Pharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $53.0M, a beta of 0.52 versus the broader market, a 52-week range of 0.395-6.5, average daily share volume of 2.2M, a public-listing history dating back to 2015, approximately 58 full-time employees. These structural characteristics shape how ATYR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.52 indicates ATYR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on ATYR?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
ATYR snapshot
As of August 14, 2026, spot at $0.57, ATM IV 401.50%, IV rank 79.85%, expected move 115.11%. The long put on ATYR below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on ATYR specifically: ATYR IV at 401.50% is rich versus its 1-year range, which makes a premium-buying ATYR long put relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 115.11% (roughly $0.66 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ATYR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ATYR should anchor to the underlying notional of $0.57 per share and to the trader's directional view on ATYR stock.
ATYR long put setup
The ATYR long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ATYR at $0.57 on that close, the first option leg uses a $0.57 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ATYR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ATYR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $0.57 | N/A |
ATYR long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
ATYR long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on ATYR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on ATYR
Long puts on ATYR hedge an existing long ATYR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ATYR exposure being hedged.
ATYR thesis for this long put
The market-implied 1-standard-deviation range for ATYR extends from approximately $-0.09 on the downside to $1.23 on the upside. A ATYR long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ATYR position with one put per 100 shares held. Current ATYR IV rank near 79.85% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on ATYR at 401.50%. As a Healthcare name, ATYR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ATYR-specific events.
ATYR long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ATYR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ATYR alongside the broader basket even when ATYR-specific fundamentals are unchanged. Long-premium structures like a long put on ATYR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ATYR chain quotes before placing a trade.
Frequently asked questions
- What is a long put on ATYR?
- A long put on ATYR is the long put strategy applied to ATYR (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ATYR stock at $0.57 on the most recent close, the strikes shown on this page are snapped to the nearest listed ATYR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ATYR long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ATYR long put priced from the end-of-day chain at a 30-day expiry (ATM IV 401.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ATYR long put?
- The breakeven for the ATYR long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ATYR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 115.11%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on ATYR?
- Long puts on ATYR hedge an existing long ATYR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ATYR exposure being hedged.
- How does current ATYR implied volatility affect this long put?
- ATYR ATM IV is at 401.50% with IV rank near 79.85%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.